The plaintiffs in Philadelphia's Risperdal mass tort are belatedly changing their legal argument in an effort to sway a judge to reconsider his ruling denying the plaintiffs a chance at punitive damages, Risperdal maker Janssen Pharmaceuticals argued in a court filing this week.
Source: http://www.law.com/jsp/law/sign_me_in.jsp?article=http://www.law.com/jsp/pa/PubArticlePA.jsp?id=1202658793025&rss=newswire
common law company law conservator
No comments:
Post a Comment